Tecovirimat for the Treatment of Mpox
NEJM • 2/25/2026 – 2/26/2026
Summary
The article titled "Tecovirimat for the Treatment of Mpox" was published in the New England Journal of Medicine, Volume 394, Issue 9, on February 26, 2026, spanning pages 884-895.
Advertisement
Lindy Score Breakdown (V4.2)
53d
Age
1
Sources
from cluster
1258
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1258/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1258/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 53 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment
Stat News • 1 day ago
A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment
Stat News • 2 days ago
STAT+: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
Stat News • Today
How Trump is pushing psychedelics reform through the health agencies
Stat News • 1 day ago
Opinion: The podcast bringing together MAHA and public health for hard conversations
Stat News • 1 day ago
Opinion: Health care is not ready for the new era of AI-enabled cyberattacks
Stat News • 2 days ago
STAT+: Kennedy focuses on affordability, combating fraud in Capitol Hill hearings
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more
Stat News • 2 days ago
Optimism for Trump’s CDC pick is tempered by questions about RFK Jr.’s role
Stat News • 1 day ago
Trump taps former public health leader Erica Schwartz to run CDC
Stat News • 2 days ago